P A Howard

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi request reprint Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, KS 66160 7231, USA
    Ann Pharmacother 40:1607-17. 2006
  2. doi request reprint Potential Interaction between clopidogrel and proton pump inhibitors
    Patricia A Howard
    School of Pharmacy, The University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA
    Am J Cardiovasc Drugs 9:353-9. 2009
  3. ncbi request reprint Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter
    P A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City 66160, USA
    Ann Pharmacother 33:38-47. 1999
  4. doi request reprint Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery
    Patricia A Howard
    Department of Pharmacy Practice, School of Pharmacy, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Ann Pharmacother 42:253-8. 2008
  5. ncbi request reprint Effectiveness of continuous infusions of loop diuretics for severe heart failure
    Patricia A Howard
    Department of Pharmacy Practice, School of Pharmacy University of Kansas Medical Center, Kansas City, Kansas 66160 7231, USA
    J Cardiovasc Med (Hagerstown) 7:5-10. 2006
  6. ncbi request reprint Heart failure drug utilization patterns for Medicaid patients before and after a heart failure-related hospitalization
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas School of Pharmacy, University Medical Center, 3901 Rainbow Boulevard, Lawrence, KS 66160 7231, USA
    Congest Heart Fail 11:124-8. 2005
  7. ncbi request reprint Nonsteroidal anti-Inflammatory drugs and cardiovascular risk
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas 66160 7231, USA
    J Am Coll Cardiol 43:519-25. 2004
  8. ncbi request reprint Low molecular weight heparins in special populations
    Patricia A Howard
    University of Kansas School of Pharmacy, USA
    J Infus Nurs 26:304-10. 2003
  9. ncbi request reprint The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation
    Patricia A Howard
    Departments of Pharmacy Practice and Cardiovascular Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7231, USA
    Pharmacoepidemiol Drug Saf 11:569-76. 2002
  10. ncbi request reprint Guidelines for stroke prevention in patients with atrial fibrillation
    P A Howard
    Department of Pharmacy Practice, School of Pharmacy, University of Kansas Medical Center, Kansas City 66160 7231, USA
    Drugs 58:997-1009. 1999

Detail Information

Publications29

  1. ncbi request reprint Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, KS 66160 7231, USA
    Ann Pharmacother 40:1607-17. 2006
    ....
  2. doi request reprint Potential Interaction between clopidogrel and proton pump inhibitors
    Patricia A Howard
    School of Pharmacy, The University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA
    Am J Cardiovasc Drugs 9:353-9. 2009
    ....
  3. ncbi request reprint Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter
    P A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City 66160, USA
    Ann Pharmacother 33:38-47. 1999
    ..To discuss the clinical pharmacology of the antiarrhythmic drug ibutilide in patients with atrial fibrillation (AF) or atrial flutter (AFl)...
  4. doi request reprint Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery
    Patricia A Howard
    Department of Pharmacy Practice, School of Pharmacy, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Ann Pharmacother 42:253-8. 2008
    ..To review the published literature evaluating the effectiveness of statin therapy for preventing postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery...
  5. ncbi request reprint Effectiveness of continuous infusions of loop diuretics for severe heart failure
    Patricia A Howard
    Department of Pharmacy Practice, School of Pharmacy University of Kansas Medical Center, Kansas City, Kansas 66160 7231, USA
    J Cardiovasc Med (Hagerstown) 7:5-10. 2006
    ....
  6. ncbi request reprint Heart failure drug utilization patterns for Medicaid patients before and after a heart failure-related hospitalization
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas School of Pharmacy, University Medical Center, 3901 Rainbow Boulevard, Lawrence, KS 66160 7231, USA
    Congest Heart Fail 11:124-8. 2005
    ..ACE inhibitors and vasodilator use remained constant. ACE-inhibitor doses were below target ranges before and after hospitalization. In this Medicaid cohort, HF-related hospitalizations did not lead to improved HF therapy...
  7. ncbi request reprint Nonsteroidal anti-Inflammatory drugs and cardiovascular risk
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas 66160 7231, USA
    J Am Coll Cardiol 43:519-25. 2004
    ..Additionally, the impact of combined therapy with aspirin and other COX inhibitors is not yet clear. This article will review the studies that have examined these issues...
  8. ncbi request reprint Low molecular weight heparins in special populations
    Patricia A Howard
    University of Kansas School of Pharmacy, USA
    J Infus Nurs 26:304-10. 2003
    ..This article will briefly review the pharmacology of LMWH and discuss usage in these special populations...
  9. ncbi request reprint The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation
    Patricia A Howard
    Departments of Pharmacy Practice and Cardiovascular Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7231, USA
    Pharmacoepidemiol Drug Saf 11:569-76. 2002
    ..To determine the frequency with which atrial fibrillation (AF) patients receiving warfarin are prescribed interacting drugs that could increase bleeding risks...
  10. ncbi request reprint Guidelines for stroke prevention in patients with atrial fibrillation
    P A Howard
    Department of Pharmacy Practice, School of Pharmacy, University of Kansas Medical Center, Kansas City 66160 7231, USA
    Drugs 58:997-1009. 1999
    ..In particular, warfarin is underutilised in high risk elderly patients. Additional studies are needed to identify barriers that prevent implementation of the clinical trial findings into clinical practice...
  11. ncbi request reprint Severe heart failure in the elderly: potential benefits of high-dose and continuous infusion diuretics
    Patricia A Howard
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City 66160 7231, USA
    Drugs Aging 19:249-56. 2002
    ..In our experience, continuous intravenous infusions are a well tolerated and effective treatment, which may shorten the duration of hospitalisation and in turn reduce the costs of treating elderly patients with HF...
  12. ncbi request reprint Patterns of ACE inhibitor use in elderly medicaid patients with heart failure
    Patricia A Howard
    University of Kansas School of Pharmacy, Department of Pharmacy Practice, Lawrence, USA
    Am J Geriatr Cardiol 11:287-94. 2002
    ..3; 95% CI, 0.34, 4.9). ACE inhibitor use in the Kansas Medicaid congestive heart failure population is not consistent with practice guidelines, particularly among older and/or nursing home patients...
  13. ncbi request reprint Aspirin resistance
    Patricia A Howard
    Department of Pharmacy, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7231, USA
    Ann Pharmacother 36:1620-4. 2002
    ..To review the literature addressing the problem of aspirin resistance in patients with vascular disease...
  14. ncbi request reprint Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients
    Theresa I Shireman
    Pharmacy Practice Department, University of Kansas School of Pharmacy, 1251 Wescoe Hall Drive, Lawrence, KS 66045, USA
    Stroke 35:2362-7. 2004
    ..Bleeding risks from combined antiplatelet-warfarin therapy have not been well-described in clinical practice. We examined antiplatelet therapy among warfarin users and the impact on major bleeding rates...
  15. ncbi request reprint Role of C-reactive protein in cardiovascular disease
    James M Backes
    Department of Pharmacy Practice, Lipid, Atherosclerosis, Metabolic and LDL Apheresis Center, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Ann Pharmacother 38:110-8. 2004
    ..To discuss the role of C-reactive protein (CRP) in cardiovascular disease as a predictor of vascular events and identify key factors that increase or decrease this inflammatory marker...
  16. ncbi request reprint Association of HMG-CoA reductase inhibitors with neuropathy
    James M Backes
    Department of Pharmacy Practice and Lipid, Atherosclerosis, Metabolic and LDL Apheresis Clinic, University of Kansas Medical Center, Kansas City, KS 66160 7231, USA
    Ann Pharmacother 37:274-8. 2003
    ..To review the possible association between statins and peripheral neuropathy...
  17. pmc Optimal lipid modification: the rationale for combination therapy
    James M Backes
    Department of Pharmacy Practice, Lipid, Atherosclerosis, Metabolic and LDL Apheresis Center, University of Kansas Medical Center, Kansas City, KS 66160 7231, USA
    Vasc Health Risk Manag 1:317-31. 2005
    ..This strategy, while potentially beneficial, has triggered concerns regarding fears of adverse effects, harmful drug interactions, and patient nonadherence...
  18. ncbi request reprint Development of a contemporary bleeding risk model for elderly warfarin recipients
    Theresa I Shireman
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Chest 130:1390-6. 2006
    ..Develop and validate a contemporary bleeding risk model to guide the clinical use of warfarin in the elderly atrial fibrillation (AF) population...
  19. ncbi request reprint Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery
    Brian J Barnes
    Department of Pharmacy Practice, School of Pharmacy, The University of Kansas Medical Center, Kansas City, Kansas 66160 7231, USA
    Ann Thorac Surg 82:1332-7. 2006
    ..We investigated the impact of AMP on the frequency and duration of POAF, the intensive care unit and hospital length of stay, and its cost-effectiveness in a risk-stratified cohort...
  20. doi request reprint Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance
    James M Backes
    Department of Pharmacy Practice, Schools of Pharmacy and Medicine, University of KansasKansas City, KS 66160, USA
    Ann Pharmacother 42:341-6. 2008
    ..Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population...
  21. ncbi request reprint Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure
    Brian J Barnes
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, KS 6610 7231, USA
    Ann Pharmacother 39:68-76. 2005
    ..To evaluate the pharmacology, pharmacokinetics, safety, and clinical use of eplerenone in heart failure (HF)...
  22. doi request reprint Does simvastatin cause more myotoxicity compared with other statins?
    James M Backes
    Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Ann Pharmacother 43:2012-20. 2009
    ..To review the literature regarding statins and myotoxicity and evaluate these data to determine whether incidence rates are higher with simvastatin...
  23. ncbi request reprint Aggressive diuresis for severe heart failure in the elderly
    P A Howard
    Department of Pharmacy, University of Kansas Medical Center, Kansas City, KS 66160-7231, USA
    Chest 119:807-10. 2001
    ..Therefore, a $4,146 billing loss was converted to $1,103 profit. CONCLUSION: IV furosemide infusion therapy for class IV heart failure in the elderly is a safe, effective, and economic mode of therapy...
  24. ncbi request reprint Warfarin for stroke prevention in octogenarians with atrial fibrillation
    P A Howard
    University of Kansas Medical Center, School of Pharmacy, 3901 Rainbow Blvd, Kansas City, KS 66160-7231, USA
    Am J Geriatr Cardiol 10:139-44. 2001
    ..27%, respectively; p < 0.05). Anticoagulation rates for high-risk patients with atrial fibrillation were low and poorly explained by stroke or bleeding risks...
  25. ncbi request reprint Do statins have a role in the management of diastolic dysfunction?
    Mazda Biria
    Mid America Cardiology, The University of Kansas Hospital and Medical Center, Kansas City, Kansas 66160 7200, USA
    Am J Cardiovasc Drugs 8:297-303. 2008
    ....
  26. ncbi request reprint High-impact articles related to the pharmacotherapeutic management of systolic heart failure
    Tien M H Ng
    School of Pharmacy, University of Southern California, Los Angeles, California, 90033, USA
    Pharmacotherapy 24:1594-633. 2004
    ..This compilation may serve as a teaching tool, reference resource, or update of the literature for pharmacy clinicians, physicians, and students...
  27. doi request reprint Role of vitamin D in cardiovascular health
    Subba Reddy Vanga
    Mid America Cardiology, Division of Cardiovascular Medicine, University of Kansas Medical Center and Hospital, Kansas City, Kansas, USA
    Am J Cardiol 106:798-805. 2010
    ..In conclusion, vitamin D is now recognized as important for cardiovascular health and its deficiency as a potential risk factor for several cardiovascular disease processes...
  28. ncbi request reprint Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis
    CoraLynn B Trewet
    University of Iowa, College of Pharmacy and Broadlawns Family Health Center, Des Moines, Iowa, USA
    Drugs Aging 24:945-55. 2007
    ..Some observational studies have also demonstrated reductions in hospitalisation but are potentially affected by non-random treatment selection...
  29. ncbi request reprint New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion
    Patricia A Howard
    Ann Pharmacother 36:1800-4. 2002